Our joints are vulnerable to so many painful conditions: arthritis, sports injuries such as muscle and meniscus tears, tendonitis and fasciitis. Medication, surgery, and other traditional therapeutic options have proven limited in addressing these disorders, often serving as a temporary “band-aid” for chronic pain and loss of mobility.
Fortunately, advancements in regenerative medicine have introduced exciting new options for treatment, and GIOSTAR Chicago is pleased to be part of this progress. We recently announced availability of our latest product: Fluid Flow, an amniotic fluid allograft containing components that help move new cells to injuries and speed the healing of damaged tissue.
Regenerative medicine develops methods to repair, regrow or replace damaged or diseased tissue, often through the use of stem cells. Rather than containing live stem cells, however, our amniotic fluid allograft product is made up of human amniotic membrane and amniotic fluid parts obtained from placental tissue of consenting mothers at the time of a full-term, live, elective Cesarean birth. The cells within amniotic fluid have long been known to contain high levels of growth factors, collagen substrates, cytokines, amino acids, and cellular components that have significant healing capabilities.
BioLab Fluid Flow™ Product Benefits
Fluid Flow is collected from donors who have been pre-screened for high-risk behaviors and relevant diseases and collected using industry standard techniques. It is then tested for potentially infectious diseases and terminally sterilized. This process ensures the safety of each liquid allograft so that it is ready to advance soft tissue repair, replacement, and reconstruction.
The Fluid Flow product can be used to treat arthritis in the hips, knees, shoulders and more, which helps combat the impact of a sedentary lifestyle. In doing so, the product minimizes discomfort and reduces the risk of diabetes, hypertension, obesity, and other side effects caused by loss of mobility. It has proven superior to many other treatments available, including narcotics, surgery and physical therapy.
The amniotic fluid allograft being offered by GIOSTAR is just the latest example of our commitment to innovation in healthcare. Other offerings include LipoRe, aesthetic services, and IV Therapies. The company takes a personalized, customized and proprietary approach to health care, using an evidence-based strategy to develop custom procedures for each patient.